Song Ding, Colin P. O'Banion, Joshua G. Welfare, David S. Lawrence
Index: 10.1016/j.chembiol.2018.03.003
Full Text: HTML
Cell-based drug delivery systems offer the prospect of biocompatibility, large-loading capacity, longin vivolifespan, and active targeting of diseased sites. However, these opportunities are offset by an array of challenges, including safeguarding the integrity of the drug cargo and the cellular host, as well as ensuring that drug release occurs at the appropriate time and place. Emerging strategies that address these, and related, issues, are described herein.
The Rheumatoid Arthritis-Associated Citrullinome
2018-04-05 [10.1016/j.chembiol.2018.03.002] |
Dependence on the Pyrimidine Biosynthetic Enzyme DHODH Is a ...
2018-04-05 [10.1016/j.chembiol.2018.03.005] |
The O-GlcNAc Transferase Intellectual Disability Mutation L2...
2018-03-29 [10.1016/j.chembiol.2018.03.004] |
Targeting Phosphopeptide Recognition by the Human BRCA1 Tand...
2018-03-29 [10.1016/j.chembiol.2018.02.012] |
Bacterial Alkaloid Biosynthesis: Structural Diversity via a ...
2018-03-29 [10.1016/j.chembiol.2018.02.013] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved